XRF Scientific: Analyse this

If you believe the resources boom still has a lot of life left, XRF Scientific might be worthy of further research.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

XRF Scientific Limited (ASX: XRF) manufactures and markets specialised chemicals and instruments for the scientific, analytical and mining industries. It produces and distributes laser plasma spectrometers which are used in the analysis of a variety of minerals, chemicals, soils and industrial material. XRF's products are particularly well suited to the mining industry for the measurement and grade of ore.

The company also supplies platinum products to laboratories, undertakes specialist repairs of equipment such as wire meshes and cathode cages. It also designs and manufactures heat-treatment furnaces, specialist furnaces, ovens and other equipment for laboratories.

Some of its clients include Campbell Brothers Limited (ASX: CPB), BHP Billiton Limited (ASX: BHP), Rio Tinto Limited (ASX: RIO), Newcrest Mining Limited (ASX: NCM) and Iluka Resources Limited (ASX: ILU).

XRF scientific doesn't compete with Campbell Brothers, with Campbell Brothers being more of a provider of laboratory and analysis services, utilising products sold by XRF Scientific.

Recent performance and Outlook

For the six months to December 2011, XRF generated revenues of $12.4m, up 44% over prior corresponding period. Net profit was up 58% to $1.62m.

Sales are up strongly in all divisions and strong organic growth is expected during 2012. The balance sheet is solid, with cash of $5m, and no material debt ($0.2m).

The company has decided not to pay dividends this period, which is sensible. Better to keep the cash and use it internally, especially when return on equity is over 15%, and likely to increase in future. Management expects the second half of the year to be stronger than the first half, based on previous history.

Campbell Brothers recently acknowledged that its mineral labs business was experiencing record levels of mineral sample flows well ahead of the previous boom period. That should be good news for XRF.

The recent acquisition of Sigma Chemicals, and 20% investment into Canadian chemical flux manufacturer Scancia also augurs well for the future.

The company has continued to focus on expanding geographically, by increasing sales into Brazil and Africa.  XRF Scientific continues to look for acquisitions to provide more products and services to the company's existing clients.

Risks

It should be fairly obvious by now, that XRF Scientific is heavily dependent on the resources sector, and that is the major risk to the business.  The more exploring, drilling and analysing that is done, the better the results for XRF. Should commodities prices fall, it's likely that there will be a fall in demand for its products, as happened in 2010, when there was a significant downturn in mining activity.

The Foolish bottom line

Directors and management hold 21.6% of the company – which is a good sign. Owners of companies have more incentive to produce good long-term reuslts, so shareholders are more likely to achieve a better outcome. The chance of a dividend for the second half of FY2012 is unlikely, but possible, with management declaring a policy of paying out 50% of net profit after tax – subject to conditions.

XRF scientific is currently trading on a forecast P/E of 9.9, despite the price rising over 21% in the last 3 months. If you believe the resources boom still has a lot of life left in it, and with its potential for growth, this P/E appears undemanding. XRF Scientific appears to be worthy of further research.

Attention: If you are looking for ASX investing ideas, look no further than "The Motley Fool's Top Stock for 2012." In this free report, Investment Analyst Dean Morel names his top pick for 2012…and beyond. Click here now to find out the name of this small but growing telecommunications company. But hurry – the report is free for only a limited period of time.

More reading

Motley Fool contributor Mike King doesn't own shares in any of the companies mentioned. The Motley Fool's purpose is to educate, amuse and enrich investors. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. Click here to be enlightened by The Motley Fool's disclosure policy

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »